ATE451120T1 - Verwendung von ziegenserum zur veterinärmedizinischen behandlung - Google Patents

Verwendung von ziegenserum zur veterinärmedizinischen behandlung

Info

Publication number
ATE451120T1
ATE451120T1 AT04820092T AT04820092T ATE451120T1 AT E451120 T1 ATE451120 T1 AT E451120T1 AT 04820092 T AT04820092 T AT 04820092T AT 04820092 T AT04820092 T AT 04820092T AT E451120 T1 ATE451120 T1 AT E451120T1
Authority
AT
Austria
Prior art keywords
veterinary medicine
goat serum
medicine treatment
treatment
medicament
Prior art date
Application number
AT04820092T
Other languages
English (en)
Inventor
Graham Peck
Juliette Peck
Original Assignee
Aimsco Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0328650A external-priority patent/GB0328650D0/en
Priority claimed from GB0404534A external-priority patent/GB0404534D0/en
Priority claimed from GB0404533A external-priority patent/GB0404533D0/en
Application filed by Aimsco Ltd filed Critical Aimsco Ltd
Application granted granted Critical
Publication of ATE451120T1 publication Critical patent/ATE451120T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04820092T 2003-12-11 2004-12-10 Verwendung von ziegenserum zur veterinärmedizinischen behandlung ATE451120T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0328650A GB0328650D0 (en) 2003-12-11 2003-12-11 Treatment equines
GB0404534A GB0404534D0 (en) 2004-03-01 2004-03-01 Treatment of canines
GB0404533A GB0404533D0 (en) 2004-03-01 2004-03-01 Treatment of canines
PCT/GB2004/050040 WO2005056053A1 (en) 2003-12-11 2004-12-10 Use of goat serum for veterinary treatment

Publications (1)

Publication Number Publication Date
ATE451120T1 true ATE451120T1 (de) 2009-12-15

Family

ID=34681900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04820092T ATE451120T1 (de) 2003-12-11 2004-12-10 Verwendung von ziegenserum zur veterinärmedizinischen behandlung

Country Status (11)

Country Link
US (5) US20080031885A1 (de)
EP (2) EP1708753B1 (de)
AT (1) ATE451120T1 (de)
AU (2) AU2004296610B2 (de)
CA (1) CA2548901C (de)
DE (1) DE602004024586D1 (de)
DK (1) DK1708753T3 (de)
ES (1) ES2337795T3 (de)
NZ (2) NZ577823A (de)
PL (1) PL1708753T3 (de)
WO (1) WO2005056053A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2877562A1 (en) 2012-06-25 2014-01-03 Aimsco Limited Formulation comprising crh and alpha-2 macroglobulin
GB201408171D0 (en) * 2014-05-08 2014-06-25 Aimsco Ltd Formulation and method of manufacture
RU2765542C1 (ru) * 2021-07-08 2022-01-31 федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) Способ прогнозирования степени тяжести острого бактериального холангиогепатита у кошек

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952194A (en) * 1996-08-01 1999-09-14 Heska Corporation Flea nucleic acid sequences and uses thereof
WO2003064472A2 (en) * 2002-01-28 2003-08-07 Aimsco Limited Treatment of ms with goat serum
EP1588597A1 (de) * 2003-01-14 2005-10-26 Koninklijke Philips Electronics N.V. Zum plazieren einer komponente auf einem substrat geegnetemaschine sowie verfahren dafür

Also Published As

Publication number Publication date
DK1708753T3 (da) 2010-04-26
US20090202522A1 (en) 2009-08-13
NZ547846A (en) 2009-07-31
ES2337795T3 (es) 2010-04-29
AU2004296610B2 (en) 2010-04-01
CA2548901C (en) 2015-07-28
EP1708753B1 (de) 2009-12-09
AU2010202668B2 (en) 2012-05-24
PL1708753T3 (pl) 2010-07-30
US20080031885A1 (en) 2008-02-07
EP2177231A2 (de) 2010-04-21
EP1708753A1 (de) 2006-10-11
DE602004024586D1 (de) 2010-01-21
US20120294951A1 (en) 2012-11-22
AU2004296610A1 (en) 2005-06-23
CA2548901A1 (en) 2005-06-23
WO2005056053A1 (en) 2005-06-23
NZ577823A (en) 2011-03-31
US20110244053A1 (en) 2011-10-06
US20140178406A1 (en) 2014-06-26
US8617553B2 (en) 2013-12-31
AU2010202668A1 (en) 2010-07-15
EP2177231A3 (de) 2012-08-15

Similar Documents

Publication Publication Date Title
DK1600510T3 (da) DNA-sekvenser med antirepressoraktivitet
MX2009006066A (es) Tratamiento de cerdos con el antigeno pcv.
BRPI0410289A (pt) ligantes do receptor de canabinóides e suas utilizações
DE60113301D1 (de) Gel für die Behandlung von Katzen und Hunden
DE602004021797D1 (de) Behandlung von alzheimer-krankheit und amyloider gehirnangiopathie
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
BRPI0409634A (pt) ligantes de receptores de canabinóides e utilização destes
ATE340568T1 (de) Verwendung einer pharmazeutischen formulierung enthaltend milchsäure oder laktat und kalium zur behandlung von hirnödem und verletzungen des gehirns
BR0308378B1 (pt) Medicamento para animais e processo para sua preparação
ATE523495T1 (de) Substituierte pyrazolinverbindungen, deren herstellung und verwendung als medikamente
ATE336177T1 (de) Hypoallergene diätetische zusammensetzung für haustiere.
ATE384437T1 (de) N-thio-nicotinamid derivate und verwandte verbindungen zur verwendung als schädlingsbekämpfungsmittel
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
DK2022786T3 (da) Middel mod mund- og klovsyge-virus til dyr, der hører til familien suidae eller får, og fremgangsmåde til forebyggelse eller behandling af mund- og klovsyge hos dyr, der hører til familien suidae eller får
DE602004024586D1 (de) Verwendung von ziegenserum zur veterinärmedizinischen behandlung
ATE298246T1 (de) Aktiviertes protein c zur behandlung von pankreatitis
EP4240389A4 (de) Virale vektoren, die für hundeinsulin kodieren, zur behandlung von stoffwechselkrankheiten bei hunden
ATE478678T1 (de) Behandlung von amyotrohper lateralsklerose
DE602004015272D1 (de) Verwendung von phenoxyessigsäurederivaten zur behandlung der hyperaktiven blase
ATE343786T1 (de) Auswertung von agenzien zur behandlung von schizophrenie
ATE478707T1 (de) Kim-1-antikörper zur behandlung von th2- vermittelten erkrankungen
ATE359088T1 (de) Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten
ATE488606T1 (de) Chemische behandlung von tierhäuten
DE602004007546D1 (de) Verwendung von pentadiensäure-derivaten zur behandlung von hyperurikämie
DE60315376D1 (de) Vorrichtung zur Behandlung von Erntegut

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1708753

Country of ref document: EP